Align Technology, Inc. $ALGN Shares Acquired by ARK Investment Management LLC

ARK Investment Management LLC increased its position in Align Technology, Inc. (NASDAQ:ALGN) by 3.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,205 shares of the medical equipment provider’s stock after buying an additional 221 shares during the period. ARK Investment Management LLC’s holdings in Align Technology were worth $1,175,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Cromwell Holdings LLC increased its position in Align Technology by 2,900.0% during the second quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 174 shares during the last quarter. SVB Wealth LLC acquired a new position in Align Technology during the first quarter worth approximately $36,000. Farther Finance Advisors LLC increased its position in Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 92 shares during the last quarter. Mather Group LLC. grew its stake in Align Technology by 375.0% during the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 345 shares during the period. Finally, Covestor Ltd grew its stake in Align Technology by 18.8% during the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after buying an additional 78 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Jefferies Financial Group reiterated a “hold” rating and set a $140.00 price objective (down from $215.00) on shares of Align Technology in a research note on Friday, October 10th. Mizuho decreased their target price on shares of Align Technology from $210.00 to $170.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. Leerink Partners decreased their target price on shares of Align Technology from $188.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, October 14th. Piper Sandler decreased their target price on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Finally, UBS Group reduced their price objective on shares of Align Technology from $160.00 to $155.00 and set a “neutral” rating on the stock in a research note on Thursday, October 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Align Technology presently has an average rating of “Hold” and an average target price of $181.67.

Align Technology Stock Down 0.5%

ALGN stock opened at $135.58 on Thursday. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $246.19. The firm’s 50-day simple moving average is $134.43 and its 200 day simple moving average is $162.85. The stock has a market cap of $9.83 billion, a PE ratio of 22.86, a price-to-earnings-growth ratio of 1.54 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period last year, the business earned $2.41 EPS. The firm’s revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. Equities analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current fiscal year.

Align Technology declared that its board has approved a stock buyback plan on Tuesday, August 5th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its shares are undervalued.

Insider Buying and Selling at Align Technology

In related news, CEO Joseph M. Hogan bought 7,576 shares of the stock in a transaction on Friday, August 1st. The shares were purchased at an average price of $131.49 per share, with a total value of $996,168.24. Following the purchase, the chief executive officer owned 184,945 shares in the company, valued at approximately $24,318,418.05. This represents a 4.27% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.66% of the stock is currently owned by company insiders.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.